Using indirect comparisons in pharmacoeconomic examination
Health technology assessment is a fundamental tool while choosing the most cost- and clinical effective technologies that are being introduced into the health system. The basis for assessment is the data of clinical studies. The experts are interested in not only the effect of a new medical technolo...
Main Authors: | Yu. E. Balykina, A. S. Kolbin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2015-03-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/43 |
Similar Items
-
Two-stage matching-adjusted indirect comparison
by: Antonio Remiro-Azócar
Published: (2022-08-01) -
Increasing transparency in indirect treatment comparisons: is selecting effect modifiers the missing part of the puzzle? A review of methodological approaches and critical considerations
by: Andreas Freitag, et al.
Published: (2023-08-01) -
Network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema
by: Maureen Watt, et al.
Published: (2023-05-01) -
Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus
by: Ian N Bruce, et al.
Published: (2022-12-01) -
Matching‐adjusted indirect comparison of isatuximab plus carfilzomib and dexamethasone with daratumumab plus lenalidomide and dexamethasone in relapsed multiple myeloma
by: Joshua Richter, et al.
Published: (2023-04-01)